Table 1.

Patients' baseline characteristics

Mean Age (yrs)	34 ± 12
M/F	36/25
Disease Duration (months)	47 ± 7
% disease beyond splenic flexure	63
% Previous ASA use	96
% Previous AZA use	11
% Previous steroid use	100